RxDoctor Payments Data

Allison Adams

Family · Bolivar, TNNPI 1174912968

Payments from drug & device makers

$1,770in general payments, 2019–2025

Across 84 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$283
  • Almirall LLC$82
  • Regeneron Healthcare Solutions, Inc.$73
  • Bayer$51
  • Nevro Corp.$41
  • plus $201 from 9 others

What the payments were for

  • Food & beverage$1,69796%
  • Education$734%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,770 in reported general payments places this provider in the 75th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$1,105
Medicare patients
29
Services billed
108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol23$19,904
JanuviaSitagliptin Phosphate25$19,124
EliquisApixaban14$16,854
JardianceEmpagliflozin23$14,937
MounjaroTirzepatide12$12,772
ShingrixVaricella-Zoster Ge/As01b/Pf25$4,551
Albuterol Sulfate HfaAlbuterol Sulfate45$1,197
Omeprazole68$1,157
Losartan Potassium67$830
Atorvastatin Calcium80$671
Famotidine48$561
Ezetimibe21$501
Gabapentin37$418
Amlodipine Besylate87$345
Duloxetine Hcl11$343

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$17$19,12425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,706 family providers in Tennessee.

Other family in Bolivar

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →